Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22390222 | 1.00 | RARB (0.36) | RARBSLC7A5TSHRKDM4CNAAA | |
| SCHEMBL13224082 | 0.98 | RARB (0.37) | RARBSLC7A5TSHRDPP4BLM | |
| SCHEMBL18672811 | 0.98 | RARB (0.37) | RARBSLC7A5TSHRDPP4BLM | |
| SCHEMBL19387347 | 0.92 | SLC7A5 (0.38) | RARBSLC7A5TSHRDPP4BLM | |
| SCHEMBL19750463 | 0.92 | SLC7A5 (0.38) | RARBSLC7A5TSHRDPP4BLM | |
| SCHEMBL19387340 | 0.92 | SLC7A5 (0.38) | RARBSLC7A5TSHRDPP4BLM | |
| SCHEMBL30058717 | 0.91 | TP53 (0.38) | RARBTSHRNAAANOD1DPP4 | |
| SCHEMBL14095430 | 0.90 | SLC7A5 (0.42) | SLC7A5TSHRNAAADPP4 | |
| SCHEMBL26231092 | 0.90 | SLC7A5 (0.42) | SLC7A5TSHRNAAADPP4 | |
| SCHEMBL26231086 | 0.90 | SLC7A5 (0.42) | SLC7A5TSHRNAAADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113677337-B | Cationic compositions based on self-neutralizing amino acids | 伊诺莱克斯投资公司 | 2025-05-23 | — | — | CN | claimed |
| US-20230092150-A1 | Self-Neutralizing Amino Acid Based Cationic Compositions | INOLEX INVESTMENT CORPORATION | 2023-03-23 | — | — | US | claimed |
| US-11540991-B2 | Self-neutralizing amino acid based cationic compositions | INOLEX INVESTMENT CORPORATION (US) | 2023-01-03 | — | — | US | claimed |
| EP-3934638-A1 | SELF-NEUTRALIZING AMINO ACID BASED CATIONIC COMPOSITIONS | Inolex Investment Corporation (US) | 2022-01-12 | — | — | EP | claimed |
| US-20200281830-A1 | Self-Neutralizing Amino Acid Based Cationic Compositions | INOLEX INVESTMENT CORPORATION (US) | 2020-09-10 | — | — | US | claimed |
| US-20230092150-A1 | Self-Neutralizing Amino Acid Based Cationic Compositions | INOLEX INVESTMENT CORPORATION | 2023-03-23 | — | — | US | disclosed |
| US-11540991-B2 | Self-neutralizing amino acid based cationic compositions | INOLEX INVESTMENT CORPORATION (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3934638-A1 | SELF-NEUTRALIZING AMINO ACID BASED CATIONIC COMPOSITIONS | Inolex Investment Corporation (US) | 2022-01-12 | — | — | EP | disclosed |
| US-20200281830-A1 | Self-Neutralizing Amino Acid Based Cationic Compositions | INOLEX INVESTMENT CORPORATION (US) | 2020-09-10 | — | — | US | disclosed |
| EP-3697879-A1 | NATURALLY DERIVED FABRIC CONDITIONING COMPOSITIONS AND RELATED METHODS | Inolex Investment Corporation (US) | 2020-08-26 | — | — | EP | disclosed |
| WO-2019079313-A1 | NATURALLY DERIVED FABRIC CONDITIONING COMPOSITIONS AND RELATED METHODS | INOLEX INVESTMENT CORPORATION (US) | 2019-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200281830-A1 | Self-Neutralizing Amino Acid Based Cationic Compositions | SLC6A15, SLC1A5, SLC6A19 | RARB 3917/4885SLC7A5 8/4885TSHR 3595/4885 |
| US-20230092150-A1 | Self-Neutralizing Amino Acid Based Cationic Compositions | SLC6A15, SLC1A5, SLC6A19 | RARB 3917/4885SLC7A5 8/4885TSHR 3595/4885 |
| US-11540991-B2 | Self-neutralizing amino acid based cationic compositions | SLC6A15, SLC1A5, SLC6A19 | RARB 3917/4885SLC7A5 8/4885TSHR 3595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.